Skip to main content
The William Harvey Research Institute - Faculty of Medicine and Dentistry

2026

Diabetic heart Drug that targets immune cells shows potential as new treatment for diabetic heart disease
27 February 2026

Researchers from Queen Mary University of London have found that a medication originally developed for glycemic control can reverse serious heart damage — not by controlling blood sugar as originally intended, but by retraining the immune system to protect the heart from within.

Surgical procedure High-risk patients account for 80% of post-surgery deaths
25 February 2026

Large UK-wide study shows that high-risk patients account for nearly 80% of post-surgery deaths, highlighting the need for open conversations and more tailored care.  

Back to top